Panagora Asset Management’s Lisata Therapeutics LSTA Stock Holding History
Bought
Maintained
Sold
Other funds holding LSTA
STA
WB
LTFS
Panagora Asset Management's LSTA Position: Q3 2019 in Review
Panagora Asset Management sold out of Lisata Therapeutics (LSTA) in Q3 2019, closing a stake of 600 shares — an estimated $21K sold.
Panagora Asset Management first reported a position in LSTA in Q2 2014 and held it in 14 quarters. The position peaked at $211K in Q4 2017. 25 funds tracked by Wall St. Rank hold LSTA as of Q3 2019.
- Panagora Asset Management reported no remaining Lisata Therapeutics position as of Q3 2019 after selling out during the quarter.
- Panagora Asset Management sold 600 Lisata Therapeutics shares in Q3 2019, an estimated $21K.
- Panagora Asset Management first reported a position in Lisata Therapeutics in Q2 2014 and held it in 14 quarters.
- Panagora Asset Management's Lisata Therapeutics position peaked at $211K in Q4 2017.
- 25 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2019.
Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.